News
Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.
December 03, 2006
News
Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...
December 03, 2006News
GE Healthcare has launched its new LightSpeed VCT XT, the industry’s first CT scanner that maintains outstanding image ...
November 29, 2006Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
An implantable technology to control high blood pressure in patients not responding to available medicines has ...
November 29, 2006News
The FDA has cleared Toshiba's new EXCELART Vantage Atlas 1.5T MRI system, which the company showcased this week during ...
November 29, 2006News
An innovative lead insulation material for cardiac leads used with pacemakers and ICDs is now FDA approved and available ...
November 29, 2006Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration.
November 29, 2006News
In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to initiating its cardiovascular clinical trials," said Christopher J. Calhoun, chief executive officer of Cytori Therapeutics. The company is developing adipose stem cells in cardiovascular disease and for use in reconstructive surgery.
November 20, 2006News
Houston based ThromboVision, Inc. has won the first annual Michael E. DeBakey Life Science Award, which carries a $50,000 cash prize to assist in propelling the company's technology toward commercial success.
November 20, 2006Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
November 2006 - Toshiba America Medical Systems, Inc. has announced a new partnership with CVCTA Education and San ...
November 20, 2006News
A German physician reports that people who have implanted pacemakers or defibrillators are not in danger of their ...
November 19, 2006News
The stent market will have a distinctly different look after Johnson & Johnson completes its acquisition of Conor ...
November 19, 2006Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
Cordis Corp. has received approval from the FDA to market its PRECISE Nitinol Stent and ANGIOGUARD Emboli Capture guide ...
November 16, 2006News
ZOLL Medical Corp. has announced it is now shipping all models of the ZOLL M Series defibrillator that comply with 2005 ...
November 16, 2006
Feature | Maureen Leahy
What doesn’t kill us, so the saying goes, makes us stronger. Those of us lucky enough to walk away from tragedy with our ...
November 16, 2006© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now